A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

Clinical trial NCT01804140 · COMPLETED

Trial details

NCT number: NCT01804140
Sponsor: Genentech, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma, Neoplasms

Start date: 2012-12-01
Primary completion: 2013-09-01
Enrollment: 662

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.